The shadow period between conclusive EMA review and BIS letting TIS know outcome, will most "interesting". In O&G terms "spud to dud or BOP thud" trading period.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025